Novel Dissymmetric Ionizable Lipid-Assembled Lipid Nanoparticles for Delivery of Ferroptosis-Related siRNA in Diabetic Treatment
This study develops novel dissymmetric ionizable lipid-based nanoparticles that efficiently deliver ferroptosis-related siRNAs to treat diabetic metabolic disorders and restore islet function in mouse models, offering a safe and potent therapeutic strategy for type 2 diabetes.